|
CCDC88B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
9.47459999345313E-09 |
| Normal-vs-Stage3 |
1.25260002370453E-09 |
| Normal-vs-Stage4 |
1.362800E-03 |
| Stage1-vs-Stage2 |
9.096600E-01 |
| Stage1-vs-Stage3 |
1.196650E-03 |
| Stage1-vs-Stage4 |
2.831400E-01 |
| Stage2-vs-Stage3 |
1.466150E-02 |
| Stage2-vs-Stage4 |
1.979380E-01 |
| Stage3-vs-Stage4 |
6.319200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
1.76625380987616E-12 |
| Normal-vs-Asian |
7.198100E-03 |
| Caucasian-vs-AfricanAmerican |
4.854600E-01 |
| Caucasian-vs-Asian |
9.951400E-01 |
| AfricanAmerican-vs-Asian |
8.325000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
5.6621374255883E-15 |
| Male-vs-Female |
1.743020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.24369967050109E-10 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
4.09494660402743E-12 |
| Normal-vs-Extreme_Obese |
3.9486000000033E-05 |
| Normal_Weight-vs-Extreme_Weight |
3.480000E-01 |
| Normal_Weight-vs-Obese |
7.863200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.966200E-01 |
| Extreme_Weight-vs-Obese |
5.280600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.888000E-01 |
| Obese-vs-Extreme_Obese |
7.563200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.64660000000683E-05 |
| Normal-vs-Age(41-60Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
2.16409999999057E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.146800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.348200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.077200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.157850E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.504800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.537620E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
2.14499973338889E-10 |
| Normal-VS-KIRP CIMP |
1.190140E-02 |
| Normal-VS-Unclassified PRCC |
2.0042001391829E-10 |
| Type1 PRCC-VS-Type2 PRCC |
2.703700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.254440E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.918200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.223200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.533620E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.030200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.33066907387547E-16 |
| Normal-vs-N1 |
7.18530000054507E-07 |
| Normal-vs-N2 |
2.10499999999669E-05 |
| N0-vs-N1 |
1.099830E-01 |
| N0-vs-N2 |
1.646790E-01 |
| N1-vs-N2 |
5.202200E-01 |
|
|
